Solventum Corp (SOLV): EBITDA
$2.67B
Year ended 2025-12-31
$2.58B
Trailing 12 months to 2026-06-30
+5.5%
3-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.67B | +67.8% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $1.59B | -29.4% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $2.25B | -0.8% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $2.27B | n/a | 2025-02-28, From 2022-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Solventum Corp (SOLV) | 2025-12-31 | $2.67B | +67.8% |
| Baxter International Inc (BAX) | 2025-12-31 | $673.00M | -33.4% |
| ResMed Inc (RMD) | 2026-06-30 | $2.09B | +10.8% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.16B | +42.3% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $4.98B | +28.6% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $5.04B | +7.6% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | -$34.00M | n/m |
| West Pharmaceutical Services Inc (WST) | 2025-12-31 | $756.30M | +4.3% |
| Globus Medical Inc (GMED) | 2025-12-31 | $756.66M | +80.4% |
Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗